These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32321803)

  • 1. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
    Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4'-Fluorouridine inhibits alphavirus replication and infection
    Yin P; May NA; Lello LS; Fayed A; Parks MG; Drobish AM; Wang S; Andrews M; Sticher Z; Kolykhalov AA; Natchus MG; Painter GR; Merits A; Kielian M; Morrison TE
    mBio; 2024 Jun; 15(6):e0042024. PubMed ID: 38700353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.
    Davuluri KS; Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
    Front Cell Infect Microbiol; 2024; 14():1335189. PubMed ID: 38895735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection.
    Albulescu IC; White-Scholten L; Tas A; Hoornweg TE; Ferla S; Kovacikova K; Smit JM; Brancale A; Snijder EJ; van Hemert MJ
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32191995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tomatidine, a natural steroidal alkaloid shows antiviral activity towards chikungunya virus in vitro.
    Troost B; Mulder LM; Diosa-Toro M; van de Pol D; Rodenhuis-Zybert IA; Smit JM
    Sci Rep; 2020 Apr; 10(1):6364. PubMed ID: 32286447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
    Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
    Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry.
    Mainou BA; Ashbrook AW; Smith EC; Dorset DC; Denison MR; Dermody TS
    J Virol; 2015 Sep; 89(17):8701-12. PubMed ID: 26109733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of nobiletin against chikungunya virus in vitro.
    Lin SC; Chen MC; Li S; Lin CC; Wang TT
    Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
    Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
    Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
    Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
    Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Host DHX9 DExH-Box Helicase Is Recruited to Chikungunya Virus Replication Complexes for Optimal Genomic RNA Translation.
    Matkovic R; Bernard E; Fontanel S; Eldin P; Chazal N; Hassan Hersi D; Merits A; Péloponèse JM; Briant L
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication.
    Di Mola A; Peduto A; La Gatta A; Delang L; Pastorino B; Neyts J; Leyssen P; de Rosa M; Filosa R
    Bioorg Med Chem; 2014 Nov; 22(21):6014-25. PubMed ID: 25282648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
    Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
    Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells.
    Hoornweg TE; van Duijl-Richter MKS; Ayala Nuñez NV; Albulescu IC; van Hemert MJ; Smit JM
    J Virol; 2016 May; 90(9):4745-4756. PubMed ID: 26912616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication.
    Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
    Phytomedicine; 2024 Jun; 128():155491. PubMed ID: 38489894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mechanism of Action of L-Tyrosine Derivatives against Chikungunya Virus Infection In Vitro Depends on Structural Changes.
    Loaiza-Cano V; Hernández-Mira E; Pastrana-Restrepo M; Galeano E; Pardo-Rodriguez D; Martinez-Gutierrez M
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription.
    Utt A; Rausalu K; Jakobson M; Männik A; Alphey L; Fragkoudis R; Merits A
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31217251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.